REQUEST FOR PROPOSAL: OMOP CDM Mapping, Training, and Consulting C-Path’s Data Collaboration Center’s Data Science Team is seeking proposals from U.S.-based vendors to provide expertise a
June 27, 2021-July 1, 2021 The Rare Disease Clinical Outcome Assessment Consortium: Collaboration Aimed at Accelerating Rare Disease Drug Development Presented at the DIA Virtual Global Annual Meeting, held June 27 – July 1, 2021.
Clinical Technology Expert and Experienced Neuroscientist Join C-Path in Executive Director Roles Scottie Kern and Dr. Terina N. Martínez Will Both Serve in Dual Positions TUCSON, Ariz., June 24, 2021 — Critical Path Instit
July 21, 2021 View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease When: July 21, 2021, 12 p.m. ET Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular
July 15, 2021-July 26, 2021 VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Critical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Cons
July 16, 2021 View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development When: June 16, 2021, 12 p.m. ET Case Study: Modeling disease progression in polycystic kidney disease to inform tr
May 19, 2021 View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database When: May 19, 2021, 12 p.m. ET Example Disease: Polycystic kidney disease and kidney transplant Presenters: Jagde
C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop, June 15-16 TUCSON, Ariz., May 2
May 20, 2021 The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation
ERA4TB Update NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted